The simultaneous overexpression of NEAT1 and DDX5 has been discovered to predict poor patient prognosis, making the NEAT1/DDX5/Wnt/β-catenin axis a potential remedial target in CRC [79, 80]. Here, DDX5 is linked to colorectal carcinoma.